By Edward Chen The recent approval of the monoclonal antibody Kisunla (donanemab-azbt) by the FDA in July 2024 marks a breakthrough in...

By Edward Chen As societies develop and become more advanced, the quality of life increases correspondingly. However, with these...

By Payton Gao My brother is 19 years old and autistic. I live in NJ with my family and we are currently registering my brother for...